Can a patient with a history of seizure disorder taking primidone (anticonvulsant) start taking Lyrica (pregabalin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient Taking Primidone Start Lyrica (Pregabalin)?

Yes, a patient taking primidone can start Lyrica (pregabalin), as pregabalin is specifically approved and effective as adjunctive therapy for partial seizures in patients already on antiepileptic drugs, with no contraindications or significant drug interactions with primidone. 1, 2

Evidence Supporting Combination Therapy

  • Pregabalin has been extensively studied as add-on therapy in patients with refractory partial epilepsy who were already taking multiple antiepileptic drugs, with 73% of study participants receiving at least two antiepileptic drugs and 23% receiving three concurrent medications 2

  • In controlled trials involving 1,052 patients, pregabalin at doses of 150-600 mg/day demonstrated significant efficacy when added to existing antiepileptic regimens, with responder rates (≥50% seizure reduction) approaching 50% at 600 mg/day 2

  • Pregabalin lacks hepatic metabolism and does not interact with cytochrome P-450 isoenzymes, explaining the absence of drug interactions with other antiepileptic medications including primidone 3

Recommended Initiation Protocol

  • Start pregabalin at 75 mg twice daily or 50 mg three times daily, with gradual titration up to 600 mg/day based on individual response and tolerability 3

  • Efficacy typically appears as early as week one of treatment, allowing for relatively rapid assessment of therapeutic benefit 2

  • Continue primidone at its current therapeutic dose while initiating pregabalin—do not reduce or discontinue the primidone during pregabalin initiation 4

Safety Monitoring Requirements

  • Monitor for dose-related adverse effects including somnolence, dizziness, and ataxia, which are the most common side effects but are generally mild to moderate in intensity and self-limiting 1, 3

  • Watch for weight gain, which occurs in approximately 14% of patients on the highest dose of 600 mg/day 1

  • Counsel patients on seizure safety precautions during the titration period, including avoiding driving, heights, and water activities until seizure control is optimized 5

Critical Considerations for Seizure Disorder Patients

  • Patients with seizure disorders should be observed closely when starting any new medication, as general guidance suggests caution with new agents in this population 6

  • The combination of primidone and pregabalin provides complementary mechanisms of action—primidone works through barbiturate-like effects while pregabalin modulates presynaptic calcium channels to inhibit excitatory neurotransmitter release 1

  • Discontinuation of pregabalin, if needed, should be gradual over at least one week to minimize withdrawal symptoms and avoid breakthrough seizures 7

References

Research

Pregabalin: an antiepileptic agent useful for neuropathic pain.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007

Guideline

Titration from Keppra to Lamictal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Breakthrough Aura in Epilepsy Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.